[息治疗对晚期癌症患者药物使用和医疗利用的影响]
Dingyi Chen1, Haoxin DU1, Yichen Zhang1
1Department of Pharmacy Administration and Clinical Pharmacy, Peking University School of Pharmaceutical sciences, Beijing 100191, China.
概括
晚期癌症患者的息护理增加了阿片类药物的使用,但显著降低了住院,ICU和手术率. 这种方法会影响药物使用和服务使用,但不会显著影响整体医疗成本.
科学领域:
- 在瘤学瘤学.
- 抚慰性护理是一种缓解性护理.
- 医疗保健服务研究 医疗服务研究
背景情况:
- 晚期癌症患者经常经历复杂的症状管理和高医疗利用率.
- 息治疗在调节药物使用,服务利用和成本方面的作用需要进一步研究.
研究的目的:
- 评估息治疗对阿片类药物消费,医疗服务利用 (住院,ICU,手术) 和晚期癌症患者的医疗支出的影响.
主要方法:
- 一个回顾性队列研究,使用北京大学癌症医院 (2018-2020) 的医疗记录.
- 粗制精确匹配用于比较接受息治疗和标准治疗的患者.
- 关键指标包括每月平均阿片类药物消费 (定义的每日剂量),住院率,ICU率,手术率和总医疗费用.
主要成果:
- 息治疗显著增加了每月平均阿片类药物消费量 (0.3 DDD/人/月,P < 0.01).
- 接受息治疗的患者的住院率 (-25.6%,P < 0.01),ICU率 (-4.9%,P < 0.01),以及手术率 (-14.5%,P < 0.01) 显著降低.
- 虽然息治疗稍微增加了2,208.8元的平均月度总成本,但这种差异在统计学上并不显著 (P=0.316).
结论:
- 息治疗与晚期癌症患者的阿片类药物消费增加有关.
- 它有效地降低了住院率,ICU入院率和手术率.
- 息治疗似乎不会对这些患者的整体医疗支出产生重大影响.
相关概念视频
01:25Continuing Care
1.9K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.9K
01:21Cancer Survival Analysis
645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645
01:15Drug Dosing: Geriatric Patients
222
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
222
01:29Therapeutic Drug Monitoring: Affecting Factors
200
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
200
01:27Nursing Ethical Principles II
2.1K
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
2.1K
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
249
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
249